Annual gross margin of global top 25 pharmas in 2014Several big name pharmas with a strategic focus on cancer treatments and oncology in particular, are below the "AVERAGE" gross margin level of these 25 pharmas that made the list. Surely Telesta, with MCNA at a margin level of 90-95%, will be like a drug they must have (once/if MCNA approved by FDA). How could they tell their shareholders they did not seriously consider acquiring Telesta???...unless Tele$ta becomes too pricey very quickly. GLTA --- https://www.statista.com/statistics/473429/top-global-pharmaceutical-companies-gross-margin-values/ --- Also, see second link for additional info relating to large biotechs' gross margin levels in Q1-15 --- https://www.statista.com/statistics/274572/gross-profit-margin-of-united-states-biotech-companies/